http://www.fiercehealthcare.com/healthcare/house-passes-landmark-medical-cures-bill-senate-to-vote-next-week?utm_medium=nl&utm_source=internal&mkt_tok=eyJpIjoiTmpNMk1tUmxOekV3TnpZMCIsInQiOiJtUTFHVmlSWVByUWJLZ1JDRjgxaklCNXlaM2hcLzRKRXBpYlE4MFwvV1BydTgyTVJvZjAxUGF5dlFUVVVVSGF6YzdETkNyUGVtY0M1eVV0OXFESWlUNEQ1dFJGeE5hamxLWTFzb1RVRVVGZ1NFPSJ9

Not everyone was on board, however. Rep. Lloyd Doggett (D-Texas) voted against the measure because he said that though the bill attempts to address the need for research funding, it doesn’t guarantee the money: “There may be bipartisan agreement, but there is not a bipartisan advancement.”

He also said the revised version of the bill grants all of big pharma’s “wish lists” and doesn’t tackle rising drug costs. Indeed, Doggett said it was appropriate that the medical cures bill is packed into a larger measure called the Tsunami Warning Bill because people who rely on lifesaving drugs and want to fill a prescription have been “buried in one wave, after another wave, after a giant wave of pharmaceutical price gouging. Whether it’s an EpiPen for a child who is going to have an allergic reaction, whether it’s for insulin for someone who is diabetic and relies on that insulin, whether it’s an oncology drug that costs over $100,000, it is wave after wave of a tsunami of price gouging.”